In a woman in her first trimester of pregnancy with a suppressed TSH of 0.28 mIU/L, what are the appropriate next steps for evaluation and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

First Trimester TSH 0.28: Next Steps

Measure free T4 (or total T4) and TSH receptor antibodies (TRAb) to distinguish between physiologic gestational TSH suppression and pathologic hyperthyroidism, as most cases of first-trimester TSH suppression are benign and require no treatment. 1, 2

Immediate Evaluation

Your patient's TSH of 0.28 mIU/L falls within the range of normal physiologic suppression during the first trimester. Here's what you need to do:

Required Laboratory Tests

  • Free T4 (or total T4 with T3): This is essential to determine if true hyperthyroidism exists 1, 2
  • TSH receptor antibodies (TRAb): Critical to distinguish Graves' disease from transient gestational hyperthyroidism 2
  • Consider TPO antibodies if not already checked

Clinical Assessment

Look specifically for:

  • Goiter with bruit or thrill - strongly suggests Graves' disease 1
  • Graves' ophthalmopathy - confirms autoimmune etiology 2
  • Hyperemesis gravidarum (5% weight loss, dehydration, ketonuria) - suggests transient gestational hyperthyroidism 1
  • Personal or family history of Graves' disease 2

Interpretation Framework

If Free T4 is Normal

No treatment is needed. 1 TSH suppression in the first trimester is physiologic due to hCG cross-reactivity with the TSH receptor. In normal pregnancy, TSH levels are typically suppressed in mid-to-late first trimester 1. Recent data shows that suppressed TSH (<0.06 mIU/L) with normal free T4 is not associated with adverse maternal or neonatal outcomes 3.

If Free T4 is Elevated

With negative TRAb: This likely represents transient gestational hyperthyroidism (TGH), occurring in 1-3% of pregnancies 2. Most women with hyperemesis gravidarum, clinical hyperthyroidism, suppressed TSH, and elevated free T4 do NOT require antithyroid drug treatment 1. TGH regresses spontaneously during the second trimester 2.

With positive TRAb: This confirms Graves' disease and requires treatment if symptomatic or if free T4 is significantly elevated 1, 2.

Important Caveats

Physiologic Variation

Be aware that TSH varies by approximately 39.5% even within a 2-hour period in pregnant women 4. A single TSH measurement may misclassify thyroid status. If clinical suspicion is low and free T4 is normal, consider repeat testing before initiating treatment.

Trimester-Specific Context

TSH reference ranges vary by gestational week within the first trimester. Up to week 6, TSH has non-pregnant reference ranges; during weeks 9-12, TSH is approximately 0.4 mIU/L lower than non-pregnancy upper limits 5. Your patient's TSH of 0.28 may be entirely normal depending on exact gestational age.

Treatment Threshold

Only treat if there is true biochemical and clinical hyperthyroidism requiring intervention. The goal is to avoid both maternal thyrotoxicosis complications (preterm delivery, intrauterine growth restriction, pre-eclampsia, fetal death) AND overtreatment leading to iatrogenic fetal hypothyroidism 1.

When to Treat

Initiate antithyroid drugs only if:

  • Free T4 is significantly elevated AND
  • Patient has clinical hyperthyroidism symptoms AND
  • TRAb is positive (confirming Graves' disease)

If treatment is needed: Use PTU in the first trimester (due to lower risk of embryopathy compared to methimazole), then switch to methimazole in the second trimester to avoid PTU-associated hepatotoxicity 1.

References

2
Guideline

graves' disease and pregnancy.

Annales d'endocrinologie, 2018

Related Questions

Given a TSH of 0.351 mIU/L, should the TSH be repeated in 4–6 weeks?
How should a pregnant patient with a TSH of 0.04 mIU/L be evaluated and managed?
How should levothyroxine be adjusted in a 26-year-old pregnant woman with Hashimoto's hypothyroidism whose pregnancy-adjusted TSH is 2.64 mIU/L?
How should a 27-year-old woman with a suppressed thyroid‑stimulating hormone (TSH) of 0.02 µIU/mL and a normal thyroxine (T4) level of 1.3 µg/dL be managed?
In a 27-year-old woman who is in early pregnancy and has hypothyroidism, how should her levothyroxine therapy be managed?
In a patient taking 50 mg clomipramine with a history of orthostatic hypertension who experiences dizziness and tinnitus upon standing, is this likely caused by clomipramine?
How should a patient who has been on amitriptyline 5 mg for two weeks and is experiencing tinnitus and anxiety taper off the medication?
Is diffuse scalp hair thinning in a child without bald patches a medical concern that warrants evaluation?
What is the mean arterial pressure (MAP) for a blood pressure of 86 mm Hg systolic and 58 mm Hg diastolic?
What is the appropriate pharmacologic treatment for a 30-year-old patient with bilateral ear pruritus due to eczema?
In a 55-year-old female smoker with confirmed influenza A infection and clinical findings suggestive of pneumonia, should oseltamivir be added to her therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.